Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.
1] Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy [2] Bone Marrow Transplant Center, R. Binaghi Hospital, Cagliari, Italy.
G
G
Caocci
Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.
F
F
Murgia
Hematology Unit, University Hospital, Sassari, Italy.
L
L
Podda
Department of Biomedical Science, University of Sassari, Sassari, Italy.
A
A
Solinas
Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy.
S
S
Atzeni
1] Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy [2] Bone Marrow Transplant Center, R. Binaghi Hospital, Cagliari, Italy.
G
G
La Nasa
D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D009570:Nitriles; D055728:Primary Myelofibrosis / Q000150:complications*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D014775:Virus Activation
D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases